APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Virus

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Selected research

Market Outlook & Growth Opportunities

Global Zika Virus Market Outlook and Growth Opportunities 2026

1 January 2026190 pages

Choose your research edition.

Industry ResearchZika Virus Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Virus Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Zika Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Virus Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Virus Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.

This report provides an overview of the global Zika Virus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Zika Virus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zika Virus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zika Virus market size, projected growth trends, production technologies, key applications, and end-use industries.

Zika Virus Segment by Company

Bharat Biotech

Inovio Pharmaceuticals and GeneOne Life Sciences

Intrexon

Cerus

Sanofi

NewLink Genetics

Immunovaccine

GlaxoSmithKline

Zika Virus Segment by Type

Molecular Test

Serologic Test

Zika Virus Segment by Application

Diagnostic Centers

Hospitals

Pathology Labs

Zika Virus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Zika Virus status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Zika Virus market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zika Virus significant trends, drivers, influence factors in global and regions.

6. To analyze Zika Virus competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zika Virus market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zika Virus industry.

Chapter 3: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Zika Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Zika Virus in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zika Virus Industry Trends Table 2. Zika Virus Industry Drivers Table 3. Zika Virus Industry Opportunities and Challenges Table 4. Zika Virus Industry Restraints Table 5. Global Zika Virus Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zika Virus Revenue Share by Company (2021-2026) Table 7. Global Zika Virus Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Zika Virus Sales Volume Share by Company (2021-2026) Table 9. Global Zika Virus Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Zika Virus Company Ranking, (2024-2026) & (USD Million) Table 11. Global Zika Virus Key Company Manufacturing Base & Headquarters Table 12. Global Zika Virus Company, Product Type & Application Table 13. Global Zika Virus Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Zika Virus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Molecular Test Table 18. Significant Companies of Serologic Test Table 19. Global Zika Virus Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Zika Virus Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Zika Virus Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Zika Virus Sales Volume Share by Type (2021-2026) Table 23. Global Zika Virus Sales Volume Share by Type (2027-2032) Table 24. Global Zika Virus Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zika Virus Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Zika Virus Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Zika Virus Sales Value Share by Type (2021-2026) Table 28. Global Zika Virus Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diagnostic Centers Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Pathology Labs Table 32. Global Zika Virus Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Zika Virus Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Zika Virus Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Zika Virus Sales Volume Share by Application (2021-2026) Table 36. Global Zika Virus Sales Volume Share by Application (2027-2032) Table 37. Global Zika Virus Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Zika Virus Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Zika Virus Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Zika Virus Sales Value Share by Application (2021-2026) Table 41. Global Zika Virus Sales Value Share by Application (2027-2032) Table 42. Global Zika Virus Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Zika Virus Sales by Region (2021-2026) & (K Units) Table 44. Global Zika Virus Sales Market Share by Region (2021-2026) Table 45. Global Zika Virus Sales by Region (2027-2032) & (K Units) Table 46. Global Zika Virus Sales Market Share by Region (2027-2032) Table 47. Global Zika Virus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Zika Virus Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Zika Virus Sales Value Share by Region (2021-2026) Table 50. Global Zika Virus Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Zika Virus Sales Value Share by Region (2027-2032) Table 52. Global Zika Virus Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Zika Virus Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Zika Virus Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Zika Virus Sales by Country (2021-2026) & (K Units) Table 57. Global Zika Virus Sales Market Share by Country (2021-2026) Table 58. Global Zika Virus Sales by Country (2027-2032) & (K Units) Table 59. Global Zika Virus Sales Market Share by Country (2027-2032) Table 60. Global Zika Virus Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Zika Virus Sales Value Market Share by Country (2021-2026) Table 62. Global Zika Virus Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Zika Virus Sales Value Market Share by Country (2027-2032) Table 64. Bharat Biotech Company Information Table 65. Bharat Biotech Business Overview Table 66. Bharat Biotech Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Bharat Biotech Zika Virus Product Portfolio Table 68. Bharat Biotech Recent Development Table 69. Inovio Pharmaceuticals and GeneOne Life Sciences Company Information Table 70. Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview Table 71. Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio Table 73. Inovio Pharmaceuticals and GeneOne Life Sciences Recent Development Table 74. Intrexon Company Information Table 75. Intrexon Business Overview Table 76. Intrexon Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Intrexon Zika Virus Product Portfolio Table 78. Intrexon Recent Development Table 79. Cerus Company Information Table 80. Cerus Business Overview Table 81. Cerus Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Cerus Zika Virus Product Portfolio Table 83. Cerus Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Sanofi Zika Virus Product Portfolio Table 88. Sanofi Recent Development Table 89. NewLink Genetics Company Information Table 90. NewLink Genetics Business Overview Table 91. NewLink Genetics Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. NewLink Genetics Zika Virus Product Portfolio Table 93. NewLink Genetics Recent Development Table 94. Immunovaccine Company Information Table 95. Immunovaccine Business Overview Table 96. Immunovaccine Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Immunovaccine Zika Virus Product Portfolio Table 98. Immunovaccine Recent Development Table 99. GlaxoSmithKline Company Information Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. GlaxoSmithKline Zika Virus Product Portfolio Table 103. GlaxoSmithKline Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Zika Virus Distributors List Table 107. Zika Virus Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Zika Virus Product Image Figure 2. Global Zika Virus Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 4. Global Zika Virus Sales (2021-2032) & (K Units) Figure 5. Global Zika Virus Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Zika Virus Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Molecular Test Image Figure 10. Serologic Test Image Figure 11. Global Zika Virus Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Zika Virus Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Zika Virus Sales Volume Share by Type (2021-2032) Figure 14. Global Zika Virus Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Zika Virus Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Zika Virus Sales Value Share by Type (2021-2032) Figure 17. Diagnostic Centers Image Figure 18. Hospitals Image Figure 19. Pathology Labs Image Figure 20. Global Zika Virus Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Zika Virus Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Zika Virus Sales Volume Share by Application (2021-2032) Figure 23. Global Zika Virus Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Zika Virus Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Zika Virus Sales Value Share by Application (2021-2032) Figure 26. Global Zika Virus Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Zika Virus Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Zika Virus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Zika Virus Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 31. North America Zika Virus Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Zika Virus Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Zika Virus Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 37. South America Zika Virus Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Zika Virus Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Zika Virus Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Zika Virus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Zika Virus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Zika Virus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Zika Virus Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Zika Virus Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Test
  • Serologic Test
Applications
  • Diagnostic Centers
  • Hospitals
  • Pathology Labs
Companies covered
  • Bharat Biotech
  • Inovio Pharmaceuticals and GeneOne Life Sciences
  • Intrexon
  • Cerus
  • Sanofi
  • NewLink Genetics
  • Immunovaccine
  • GlaxoSmithKline

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zika Virus Sales Value (2021-2032)
  4. 1.2.2 Global Zika Virus Sales Volume (2021-2032)
  5. 1.2.3 Global Zika Virus Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Zika Virus Market Dynamics
  1. 2.1 Zika Virus Industry Trends
  2. 2.2 Zika Virus Industry Drivers
  3. 2.3 Zika Virus Industry Opportunities and Challenges
  4. 2.4 Zika Virus Industry Restraints
3 Zika Virus Market by Company
  1. 3.1 Global Zika Virus Company Revenue Ranking in 2025
  2. 3.2 Global Zika Virus Revenue by Company (2021-2026)
  3. 3.3 Global Zika Virus Sales Volume by Company (2021-2026)
  4. 3.4 Global Zika Virus Average Price by Company (2021-2026)
  5. 3.5 Global Zika Virus Company Ranking (2024-2026)
  6. 3.6 Global Zika Virus Company Manufacturing Base and Headquarters
  7. 3.7 Global Zika Virus Company Product Type and Application
  8. 3.8 Global Zika Virus Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Zika Virus Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Zika Virus Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Zika Virus Market by Type
  1. 4.1 Zika Virus Type Introduction
  2. 4.1.1 Molecular Test
  3. 4.1.2 Serologic Test
  4. 4.2 Global Zika Virus Sales Volume by Type
  5. 4.2.1 Global Zika Virus Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zika Virus Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Zika Virus Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Zika Virus Sales Value by Type
  9. 4.3.1 Global Zika Virus Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zika Virus Sales Value by Type (2021-2032)
  11. 4.3.3 Global Zika Virus Sales Value Share by Type (2021-2032)
5 Zika Virus Market by Application
  1. 5.1 Zika Virus Application Introduction
  2. 5.1.1 Diagnostic Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Pathology Labs
  5. 5.2 Global Zika Virus Sales Volume by Application
  6. 5.2.1 Global Zika Virus Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zika Virus Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Zika Virus Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Zika Virus Sales Value by Application
  10. 5.3.1 Global Zika Virus Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Zika Virus Sales Value by Application (2021-2032)
  12. 5.3.3 Global Zika Virus Sales Value Share by Application (2021-2032)
6 Zika Virus Regional Sales and Value Analysis
  1. 6.1 Global Zika Virus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zika Virus Sales by Region (2021-2032)
  3. 6.2.1 Global Zika Virus Sales by Region: 2021-2026
  4. 6.2.2 Global Zika Virus Sales by Region (2027-2032)
  5. 6.3 Global Zika Virus Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Zika Virus Sales Value by Region (2021-2032)
  7. 6.4.1 Global Zika Virus Sales Value by Region: 2021-2026
  8. 6.4.2 Global Zika Virus Sales Value by Region (2027-2032)
  9. 6.5 Global Zika Virus Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Zika Virus Sales Value (2021-2032)
  12. 6.6.2 North America Zika Virus Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Zika Virus Sales Value (2021-2032)
  15. 6.7.2 Europe Zika Virus Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Zika Virus Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Zika Virus Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Zika Virus Sales Value (2021-2032)
  21. 6.9.2 South America Zika Virus Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Zika Virus Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Zika Virus Sales Value Share by Country, 2025 VS 2032
7 Zika Virus Country-level Sales and Value Analysis
  1. 7.1 Global Zika Virus Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zika Virus Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Zika Virus Sales by Country (2021-2032)
  4. 7.3.1 Global Zika Virus Sales by Country (2021-2026)
  5. 7.3.2 Global Zika Virus Sales by Country (2027-2032)
  6. 7.4 Global Zika Virus Sales Value by Country (2021-2032)
  7. 7.4.1 Global Zika Virus Sales Value by Country (2021-2026)
  8. 7.4.2 Global Zika Virus Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Zika Virus Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Zika Virus Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Zika Virus Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Zika Virus Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Zika Virus Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Zika Virus Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Zika Virus Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Zika Virus Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Zika Virus Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Zika Virus Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Zika Virus Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Zika Virus Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Zika Virus Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Zika Virus Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Zika Virus Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Zika Virus Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Zika Virus Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Zika Virus Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Zika Virus Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Zika Virus Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Zika Virus Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Zika Virus Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Zika Virus Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Zika Virus Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Zika Virus Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Zika Virus Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Zika Virus Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Zika Virus Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Zika Virus Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Zika Virus Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Zika Virus Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Zika Virus Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Zika Virus Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Zika Virus Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Zika Virus Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Zika Virus Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Zika Virus Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Zika Virus Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Zika Virus Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Zika Virus Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Zika Virus Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Zika Virus Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Zika Virus Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Zika Virus Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Zika Virus Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Zika Virus Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Zika Virus Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Zika Virus Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Zika Virus Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Zika Virus Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Zika Virus Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Zika Virus Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Zika Virus Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Zika Virus Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Zika Virus Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Zika Virus Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Zika Virus Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Zika Virus Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Zika Virus Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Zika Virus Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Zika Virus Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Zika Virus Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Zika Virus Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Zika Virus Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Zika Virus Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Zika Virus Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Zika Virus Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Zika Virus Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Zika Virus Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Zika Virus Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Zika Virus Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Zika Virus Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Zika Virus Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Zika Virus Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Zika Virus Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Zika Virus Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Zika Virus Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Zika Virus Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Zika Virus Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Zika Virus Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Zika Virus Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Zika Virus Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Zika Virus Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Zika Virus Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Zika Virus Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Zika Virus Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 Inovio Pharmaceuticals and GeneOne Life Sciences
  8. 8.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
  9. 8.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview
  10. 8.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio
  12. 8.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments
  13. 8.3 Intrexon
  14. 8.3.1 Intrexon Company Information
  15. 8.3.2 Intrexon Business Overview
  16. 8.3.3 Intrexon Zika Virus Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Intrexon Zika Virus Product Portfolio
  18. 8.3.5 Intrexon Recent Developments
  19. 8.4 Cerus
  20. 8.4.1 Cerus Company Information
  21. 8.4.2 Cerus Business Overview
  22. 8.4.3 Cerus Zika Virus Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cerus Zika Virus Product Portfolio
  24. 8.4.5 Cerus Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Zika Virus Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Zika Virus Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 NewLink Genetics
  32. 8.6.1 NewLink Genetics Company Information
  33. 8.6.2 NewLink Genetics Business Overview
  34. 8.6.3 NewLink Genetics Zika Virus Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NewLink Genetics Zika Virus Product Portfolio
  36. 8.6.5 NewLink Genetics Recent Developments
  37. 8.7 Immunovaccine
  38. 8.7.1 Immunovaccine Company Information
  39. 8.7.2 Immunovaccine Business Overview
  40. 8.7.3 Immunovaccine Zika Virus Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Immunovaccine Zika Virus Product Portfolio
  42. 8.7.5 Immunovaccine Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Zika Virus Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Zika Virus Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zika Virus Value Chain Analysis
  2. 9.1.1 Zika Virus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zika Virus Sales Mode & Process
  6. 9.2 Zika Virus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zika Virus Distributors
  9. 9.2.3 Zika Virus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst